| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3830021 | ADME | Drug level in rat primary hepatocytes treated with JNJ-54257099 at 2 to 62.5 uM after 24 hrs using radiolabeled compound by LC-MS/MS analysis | Rattus norvegicus | 2 | ALA3826882 | cell-based format | Scientific Literature | |
| 2. | ALA3830022 | ADME | Drug level in dog primary hepatocytes treated with JNJ-54257099 at 2 to 62.5 uM after 4 hrs using radiolabeled compound by LC-MS/MS analysis | Canis lupus familiaris | 2 | ALA3826882 | cell-based format | Scientific Literature | |
| 3. | ALA3830026 | ADME | Drug level in human hepatocytes treated with JNJ-54257099 in presence of CYP2C8 and CYP2C9 inhibitor montelukast by LC-MS/MS analysis | Homo sapiens | 2 | ALA3826882 | cell-based format | Scientific Literature | |
| 4. | ALA3830519 | ADME | Drug level in human hepatocytes treated with JNJ-54257099 in presence of PDE4 inhibitor rolipram by LC-MS/MS analysis | Homo sapiens | 1 | ALA3826882 | cell-based format | Scientific Literature | |
| 5. | ALA3830638 | ADME | Drug level in human hepatocytes treated with JNJ-54257099 in presence of pan-PDE inhibitor ibudilast by LC-MS/MS analysis | Homo sapiens | 1 | ALA3826882 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!